Story thread · 4 reports / 4 sources

Novartis' drug delivery deal with Alteogen; More worker cuts at Cellares

endpts.com · 11d

Plus, news about Novonesis, Aspen, Fortrea and Northway. Alteogen and Novartis make a deal: The Swiss pharma is licensing Alteogen’s hyaluronidase enzyme, called ALT-B4, which is manufactured using a tech platform ...

First report: Alteogen signs deal with Novartis worth up to 4.4 tln won for subcutaneous formulations — en.yna.co.kr, 13d

The coverage

Novartis and Alteogen ink injectable drug delivery deal worth up to $3.2B
seekingalpha.com · 12d
Alteogen Enters Option and License Agreement with Novartis for Development and Commercialization of Hybrozyme™-Enabled Subcutaneous Products
laotiantimes.com · 12d

The conversation · 0

No comments yet — start the thread.